bpc-157 safety evidence BPC-157: The peptide with big claims and scant BPC-157: Experimental Peptide Creates Risk

Vitamwardsin B12 sources and bioavailability. Experimental Biology and Medicine 232(10) (2007): 12661274

The natty plus protocol is a good framework if youre combining peptides with other non-hormonal performance aids

A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent, wherein the therapeutic agent is an antioxidant or anti-apoptotic agent, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration

The PRISMA 2020 flow diagram was generated using the PRISMA2020 R package and Shiny app (Haddaway et al